Identification of novel altered peptide ligands recognized by human tumor-reactive T cells

被引：0
|
作者：
Fallahi, A
Li, Y
Pinilla, C
Yee, C
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[2] Torrey Pines Inst Mol Studies, San Diego, CA USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2006年 / 54卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
50
引用
收藏
页码：S88 / S88
页数：1
相关论文
共 50 条
  • [41] Redirecting αβT cells against cancer cells by transfer of a broadly tumor-reactive γδT-cell receptor
    Marcu-Malina, Victoria
    Heijhuurs, Sabine
    van Buuren, Marit
    Hartkamp, Linda
    Strand, Susanne
    Sebestyen, Zsolt
    Scholten, Kirsten
    Martens, Anton
    Kuball, Juergen
    BLOOD, 2011, 118 (01) : 50 - 59
  • [42] Identification, profiling and clonotypic tracking of tumor-reactive T cells derived from bronchoalveolar lavage in lung cancer patients
    Ryu, Heeju
    Sun, Wei
    Wurscher, Michelle A.
    Nair, Viswam S.
    Newell, Evan W.
    CANCER RESEARCH, 2024, 84 (06)
  • [43] Detection of HLA-independent tumor-reactive T cells in umbilical cord blood
    Pannenbeckers, M.
    Derigs, P.
    Fruth, A.
    Paschen, A.
    Woelfel, T.
    Woelfel, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 137 - 137
  • [44] Mucin may not be the recognition antigen for autologous and heterologous pancreatic tumor-reactive T cells
    Selvan, RS
    10TH INTERNATIONAL CONGRESS ON IMMUNOLOGY, VOLS 1 AND 2, 1998, : 1123 - 1127
  • [45] Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL
    Chen, JL
    Dunbar, PR
    Gileadi, U
    Jäger, E
    Gnjatic, S
    Nagata, Y
    Stockert, E
    Panicalli, DL
    Chen, YT
    Knuth, A
    Old, LJ
    Cerundolo, V
    JOURNAL OF IMMUNOLOGY, 2000, 165 (02): : 948 - 955
  • [46] CD137 as a Biomarker for Tumor-Reactive T Cells: Finding Gold in the Desert
    Zhu, Yuwen
    Chen, Lieping
    CLINICAL CANCER RESEARCH, 2014, 20 (01) : 3 - 5
  • [47] The impact of antibiotic usage on the efficacy of chemoimmunotherapy is contingent on the source of tumor-reactive T cells
    Kuczma, Michal P.
    Ding, Zhi-Chun
    Li, Tao
    Habtetsion, Tsadik
    Chen, Tingting
    Hao, Zhonglin
    Bryan, Locke
    Singh, Nagendra
    Kochenderfer, James N.
    Zhou, Gang
    ONCOTARGET, 2017, 8 (67) : 111931 - 111942
  • [48] Cancer-driven exhaustion of tumor-reactive γδ-T cells: Relevance to immunosurveillance and immunotherapy
    Beck, Benjamin H.
    Kim, Hyung-Gyoon
    Haines, Hilary
    Feeley, Kyle
    Lopez, Richard
    CANCER RESEARCH, 2010, 70
  • [49] PROSTATE CANCER IMMUNOTHERAPY USING BI-SPECIFIC TUMOR-REACTIVE T CELLS
    Chan, Robert
    Leen, Ann
    Brenner, Malcolm
    Palapattu, Ganesh
    Vera, Juan
    JOURNAL OF UROLOGY, 2012, 187 (04): : E530 - E530
  • [50] Impact of Cysteine Residues on MHC Binding Predictions and Recognition by Tumor-Reactive T Cells
    Sachs, Abraham
    Moore, Eugene
    Kosaloglu-Yalcin, Zeynep
    Peters, Bjoern
    Sidney, John
    Rosenberg, Steven A.
    Robbins, Paul F.
    Sette, Alessandro
    JOURNAL OF IMMUNOLOGY, 2020, 205 (02): : 539 - 549
12345